Saint Charles Hospital Chemical Dependency Inpatient Program

Saint Charles Hospital Chemical Dependency Inpatient Program

Services:
Medical Services
• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

External Opioid Medications Source

• In-network prescribing entity
• No formal relationship with prescribing entity

Gender Accepted

• Male
• Female

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• No formal relationship with prescribing entity

Payment/Insurance/Funding Accepted

• Private health insurance
• Medicaid
• State-financed health insurance plan other than Medicaid
• Federal military insurance (e.g., TRICARE)
• Cash or self-payment
• Medicare

Assessment/Pre-treatment

• Screening for tobacco use
• Screening for mental disorders
• Complete medical history/physical exam
• Comprehensive substance use assessment
• Screening for substance use
• Professional interventionist/educational consultant

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Ancillary Services

• Social skills development
• Mental health services

Facility Vaping Policy

• Vaping not permitted

Hospitals

• General Hospital (including VA hospital)

Facility Smoking Policy

• Smoking not permitted

Education and Counseling Services

• Family counseling
• Hepatitis education, counseling, or support
• HIV or AIDS education, counseling, or support
• Substance use disorder education
• Group counseling
• Health education services other than HIV/AIDS or hepatitis
• Smoking/vaping/tobacco cessation counseling
• Individual counseling

Type of Opioid Treatment

• Prescribes buprenorphine
• Buprenorphine maintenance
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere

Type of Care

• Substance use treatment

License/Certification/Accreditation

• State department of health
• State Substance use treatment agency
• The Joint Commission
• Hospital licensing authority

Special Programs/Groups Offered

• Clients with co-occurring pain and substance use disorders
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Clients with HIV or AIDS
• Adult women
• Seniors or older adults
• Adult men
• Clients who have experienced trauma
• Clients who have experienced intimate partner violence, domestic violence
• Pregnant/postpartum women
• Criminal justice (other than DUI/DWI)/Forensic clients
• Clients who have experienced sexual abuse
• Clients with co-occurring mental and substance use disorders
• Veterans

Transitional Services

• Aftercare/continuing care
• Outcome follow-up after discharge
• Discharge Planning
• Naloxone and overdose education

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Pharmacotherapies

• Naltrexone (extended-release, injectable)
• Buprenorphine (extended-release, injectable)
• Disulfiram
• Medication for mental disorders
• Non-nicotine smoking/tobacco cessation
• Nicotine replacement
• Buprenorphine without naloxone
• Naltrexone (oral)
• Buprenorphine with naloxone
• Medications for HIV treatment
• Acamprosate (Campral®)
• Clonidine

Recovery Support Services

• Assistance with obtaining social services
• Housing services
• Self-help groups

Testing

• HIV testing
• STD testing
• TB screening
• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• Drug and alcohol oral fluid testing
• Drug or alcohol urine screening

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Hospital inpatient treatment
• Hospital inpatient/24-hour hospital inpatient

Treatment Approaches

• Brief intervention
• Cognitive behavioral therapy
• Relapse prevention
• Motivational interviewing
• 12-step facilitation
• Substance use disorder counseling

Age Groups Accepted

• Adults
• Young Adults

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder